William P.D. Hendricks

Author

Translational Genomics Research Institute

Also Known As

Abudu, Aierken, Hendricks, William P.D., Huntsman, David G., W Hendricks, W. Hendricks, William Hendricks, William P D Hendricks, William P. D. Hendricks, William P. Hendricks, William P.D. Hendricks

176

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Translational Genomics Research Institute University of North Carolina at Chapel Hill University of British Columbia Mayo Clinic in Arizona BC Cancer Agency

About

William P.D. Hendricks is an author at Translational Genomics Research Institute specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Natural Sciences	3	3	202
3	Health Sciences	1	1	13
4	Biochemistry	1	1	56
5	Biology	1	1	43

William P.D. Hendricks

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 Pilar Ramos, Anthony N. Karnezis, David W. Craig, Nature Genetics Somatic VariantSomatic MutationsMedicineHypercalcemic TypeSmall Cell Carcinoma	2014	376
Dual loss of the <scp>SWI</scp>/<scp>SNF</scp> complex <scp>ATPases SMARCA4</scp>/<scp>BRG1</scp> and <scp>SMARCA2</scp>/<scp>BRM</scp> is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type Anthony N. Karnezis, Yemin Wang, Pilar Ramos, The Journal of Pathology	2015	218
Integrated genomic analyses reveal frequent <i>TERT</i> aberrations in acral melanoma Winnie S. Liang, William P.D. Hendricks, Jeffrey Kiefer, Genome Research	2017	138
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type Leora Witkowski, Catherine Goudie, Pilar Ramos, Gynecologic Oncology Cancer RiskMedicineHypercalcemic TypeSmall Cell CarcinomaPathology	2016	125
Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2 Heather L. Gardner, Karthigayini Sivaprakasam, Natalia Briones, Communications Biology	2019	123
A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters Hyun-Jin Kang, Yunxi Cui, Holly Yin, Journal of the American Chemical Society Cell DeathCancer BiologyTumor BiologyTranscriptional RegulationTelomere Length	2016	103
The histone methyltransferase <scp>EZH2</scp> is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type Yemin Wang, Shary Yuting Chen, Anthony N. Karnezis, The Journal of Pathology	2017	103
Diagnostic and prognostic significance of genetic regional heterogeneityin meningiomas Wolfgang Pfisterer, Nicole Hank, Mark C. Preul, Neuro-Oncology	2004	80
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer Raffaella Soldi, Tithi Ghosh, Alexis Weston, PLoS ONE Molecular BiologyAnti-tumor ImmunityCancer BiologyEpigeneticsTumor Biology	2020	80
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type Yemin Wang, Shary Yuting Chen, Shane Colborne, Molecular Cancer Therapeutics	2018	74

Page 1